Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $14.12 USD
Change Today +0.54 / 3.98%
Volume 674.7K
RGLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - regulus therapeutics inc (RGLS)

NameBoard RelationshipsTitleAge
Kleanthis G. Xanthopoulos Ph.D.138 RelationshipsChief Executive Officer, President and Director56
David L. Szekeres 4 RelationshipsPrincipal Financial & Accounting Officer, Chief Business Officer, General Counsel and Secretary40
Martin Beaulieu Ph.D.No RelationshipsHead of Regulus Micromarkers(TM)--
Paul C. Grint M.D.11 RelationshipsChief Medical Officer56

Board Members - regulus therapeutics inc (RGLS)

NameBoard RelationshipsPrimary CompanyAge
Stelios Papadopoulos Ph.D.91 RelationshipsExelixis, Inc.66
Kleanthis G. Xanthopoulos Ph.D.138 RelationshipsRegulus Therapeutics Inc.56
David Baltimore Ph.D.118 RelationshipsAriad Pharmaceuticals Inc.76
Bruce L. A. Carter Ph.D.211 RelationshipsXencor, Inc.71
Mark G. Foletta CPA37 RelationshipsIslet Sciences, Inc53

Executive Committees* - regulus therapeutics inc (RGLS)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeMark G. Foletta CPA 37 Relationships2 Executives
Compensation CommitteeBruce L. A. Carter Ph.D. 211 Relationships3 Executives
Nominating CommitteeDavid Baltimore Ph.D. 118 Relationships3 Executives
Corporate Governance CommitteeDavid Baltimore Ph.D. 118 Relationships3 Executives
View RGLS Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $14.12 USD +0.54

RGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RGLS.
View Industry Companies
 

Industry Analysis

RGLS

Industry Average

Valuation RGLS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.